• 1.

    Watt G, Kantipong P, Jongsakul K, 2003. Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin Infect Dis 36: 10671069.

    • Search Google Scholar
    • Export Citation
  • 2.

    Mendes W da S, Branco M dos R, Medeiros MN, 2006. Clinical case report: dengue hemorrhagic fever in a patient with acquired immunodeficiency syndrome. Am J Trop Med Hyg 74: 905907.

    • Search Google Scholar
    • Export Citation
  • 3.

    Siong WC, Ching TH, Jong GC, Pang CS, Vernon LJ, Sin LY, 2008. Dengue infections in HIV patients. Southeast Asian J Trop Med Public Health 39: 260265.

    • Search Google Scholar
    • Export Citation
  • 4.

    Gonzalez D, Limonta D, Bandera JF, Perez J, Kouri G, Guzman MG, 2009. Dual infection with dengue virus 3 and human immunodeficiency virus 1 in Havana, Cuba. J Infect Dev Ctries 3: 318320.

    • Search Google Scholar
    • Export Citation
  • 5.

    Xiang J, George SL, Wünschmann S, Chang Q, Klinzman D, Stapleton JT, 2004. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 363: 20402046.

    • Search Google Scholar
    • Export Citation
  • 6.

    De Clercq E, Schols D, 2001. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. Antivir Chem Chemother 1: 1931.

    • Search Google Scholar
    • Export Citation
  • 7.

    McLinden JH, Stapleton JT, Chang Q, Xiang J, 2008. Expression of the dengue virus type 2 NS5 protein in a CD4(+) T cell line inhibits HIV replication. J Infect Dis 198: 860863.

    • Search Google Scholar
    • Export Citation
  • 8.

    Vicenzi E, Poli G, 2005. Detection and analyses of HIV: infection of CD4+ primary T cells and cell lines, generation of chronically infected cell lines, and induction of HIV expression. Curr Protoc Immunol 12: 3.

    • Search Google Scholar
    • Export Citation
  • 9.

    Sutthent R, Gaudart N, Chokpaibulkit K, Tanliang N, Kanoksinsombath C, Chaisilwatana P, 2003. p24 antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J Clin Microbiol 41: 10161022.

    • Search Google Scholar
    • Export Citation
  • 10.

    Xiang J, McLinden JH, Rydze RA, Chang Q, Kaufman TM, Klinzman D, Stapleton JT, 2009. Viruses within the flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells. J Immunol 183: 110.

    • Search Google Scholar
    • Export Citation
  • 11.

    Oishi K, Saito M, Mapua CA, Natividad FF, 2007. Dengue illness: clinical features and pathogenesis. J Infect Chemother 13: 125133.

  • 12.

    Mathew A, Rothman AL, 2008. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 225: 300313.

  • 13.

    Lei HY, Huang KJ, Lin YS, Yeh TM, Liu HS, Liu CC, 2008. Immunopathogenesis of dengue hemorrhagic fever. Am J Infect Dis 4: 19.

  • 14.

    Pang T, Cardosa MJ, Guzman MG, 2007. Of cascades and perfect storms: the immunopathogenesis of dengue hemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 85: 4345.

    • Search Google Scholar
    • Export Citation
  • 15.

    Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC, 2001. Immunopathogenesis of dengue virus infection. J Biomed Sci 8: 377388.

  • 16.

    Hill CS, Treisman R, 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80: 199211.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dengue Virus Serotype 1 Non-Structural Protein NS5 Expression Interferes with HIV Replication in a CD4+ T-Cell Line

View More View Less
  • Faculty of Medicine, University of Colima, Colima, Mexico; Center for Biomedical Research, University of Colima, Colima, Mexico; Department of Emerging Diseases and Emergencies, Institute for Epidemiological Diagnosis and Reference, Mexico City, Mexico

Author Notes

* Address correspondence to Uriel A. López-Lemus, Avenue 25 de Julio, No. 965, Villas de San Sebastián, 2804 Colima, México. E-mail: lemus_a83@yahoo.com

Financial support: This protocol was financed by InDRE-R33, Universidad de Colima - Ramón Álvarez-Buylla de Aldana (UCOL-FRABA)-750/11, and Fondo Institucional de Fomento Regional para el Desarrollo Científico, Tecnológico y de Innovación - Consejo Nacional de Ciencia y Tecnología (FORDECYT-CONACYT) (ID 2009/1-000000000117535) research grants.

Authors' addresses: Uriel A. López-Lemus, Faculty of Medicine, University of Colima, Colima, Mexico, E-mail: lemus_a83@yahoo.com. Clemente Vásquez and Salvador Valle-Reyes, Biomedical Sciences, University of Colima, Colima, Mexico, E-mails: clemvas@ucol.mx and valle_salvador@hotmail.com. Roberto Vázquez-Campuzano and Carmen Guzmán-Bracho, Department of Emerging Diseases and Emergencies, Institute of Epidemiological Diagnosis and Reference, Mexico City, Mexico, E-mails: rvzqzroberto@yahoo.com and carmen.guzman@salud.gob.mx. Diego Araiza-Garaygordobil, Nicte Rebolledo-Prudencio, Iván Delgado-Enciso, and Francisco Espinoza-Gómez, Public Health, University of Colima, Colima, Mexico, E-mails: elezkato@hotmail.com, nicte1331@hotmail.com, ivan_delgado_enciso@ucol.mx, and fespin@ucol.mx.

Save